Table 2.
Comorbidities and complications at baseline
| SHPT/CKD-HD* (n = 282) | |
|---|---|
| Comorbidities | |
| Hypertension | 236 (83.7) |
| Diabetes | 152 (53.9) |
| Diabetes type 2 | 123 (43.6) |
| Diabetes type 1 | 16 (5.7) |
| Heart failure | 98 (34.8) |
| Cardiovascular eventa | 90 (31.9) |
| Hypercholesterolemia | 59 (20.9) |
| Stroke | 46 (16.3) |
| Ischemic stroke | 22 (7.8) |
| Non-ischemic stroke | 6 (2.1) |
| Myocardial infarction | 43 (15.2) |
| NSTEMI/STEMIb | 7 (2.5) |
| Valvular or vascular calcification | 37 (13.1) |
| Peripheral artery disease | 23 (8.2) |
| Hypothyroidism | 19 (6.7) |
| Transient ischemic attack | 14 (5.0) |
| Carotid artery disease | 7 (2.5) |
| Liver impairment | 1 (0.4) |
| Complications | |
| Diabetic nephropathy | 84 (29.8) |
| Retinopathy | 62 (22.0) |
| Fractures | 59 (20.9) |
| Diabetic foot | 11 (3.9) |
*Data indicate single diagnostic labels found in patients’ EHRs (i.e., if diagnostic information for a given condition exists multiple times for a single patient, the condition was counted only once). Of note, a single patient could have been diagnosed with more than one of the analyzed comorbidities.
aCardiovascular event includes stroke, myocardial infarction, unstable angina, and/or coronary revascularization.
b(Non/N) ST-segment elevation myocardial infarction.